Our Services
Core Team
Consulting Network
Resources
- Case Studies
- Blog
- News
- Whitepapers
Careers
Contact

Biotech and Pharmaceutical Consulting

vaccines

These selected case studies illustrate the scope of our work, the level of expertise we’re able to offer, and our consistent record of successful engagements.

Location: Resources
Case Studies
vaccines

Case Study Index

By Service Area

Business Development
Product Development
Strategy & Commercialization

By Functional Discipline

Asset Scouting
Business Strategy
Clinical Development
Due Diligence
Expert Witness
Launch Planning
New Product Planning
Opportunity Mapping
Partnering and deal-making
Pharma Licensing
Preclinical Development
Regulatory Affairs
Research and IP evaluation
Valuations

By Technology

Antibodies, ADCs
Cell Therapy
Discovery Platforms
Gene Therapy
Immunotherapy
Peptides & Proteins
Radiopharmaceuticals
Small Molecules
Vaccines

Interim medical director for MAA submission

Challenge: On behalf of a European pharmaceutical company, one of Alacrita’s professionals acted as medical director for the registration of a new agent in a neuroendocrine indication in territories...

Developing vaccine products

Challenge The UK HIV Vaccines Consortium needed expert advice. The consortium was supporting and coordinating the development of several new HIV vaccines in academia. They needed guidance about which...

Applying to Early Access to Medicines (EAMS) at the MHRA

Challenge: Our client was developing oncolytic viruses for treating a rare form of brain cancer. Its lead product had been successfully evaluated in a Phase I dose-escalation study. Direct injection...

Due diligence on the developability & investability of a cancer vaccine

Challenge: A newly-formed US biotech company has acquired the intellectual property and assets of a legacy cancer vaccine company that had ceased trading several years ago following disappointing...

Investor due diligence on preclinical stage vaccine platform technology

Challenge: Following a pre-due diligence exercise, an investment firm asked Alacrita to conduct a deeper due diligence on a biotech company's vaccine platform technology targeted towards infectious...

Clinical strategies for a novel peptide-based cancer vaccine

Challenge: A US-based cancer vaccine company developing a peptide-based product was in clinical trials in its lead indication. Recent laboratory research had revealed the target antigens were also...

Cancer vaccine clinical strategy, valuation and business planning

Alacrita Consulting's founders worked together for over 10 years at Onyvax, a London-based cancer immunotherapy company backed by SR One. We have conducted a number of consulting projects in the...

1

Need biotech consulting support? We can help.

Contact us today to learn how our pharma & biotech consulting expertise can serve your project.

Contact us

Explore our biotech & life science consulting services

Strategy and Commercialization Learn more
Product Development Learn more
Business Development Learn more

© 2023 Alacrita Holdings Limited | Pharma & Biotech Consulting

Privacy Notice

Alacrita Consulting
2 Royal College St
London, UK
NW1 0NH

Registered in England & Wales.
No. 10530608

One Broadway
Floor 14
Cambridge, MA 02142

Registered in Massachusetts.